Objective: Urinary incontinence (UI) is one of the most common urinary system diseases that mostly affects womenbut alsomen.We evaluated the therapeutic efficacy of functional magnetic stimulation (FMS) as potential UI treatmentwith improvements in the pelvic floor musculature, urodynamic tests and quality of life.Methods: A total of 20 UI patients (10 females and 10 men, mean age 64, 14 years), including 10 with stress UI,four with urgency UI and six with mixed UI, were treated with FMS (20min/session) twice a week for 3 weeks.The patients’ impressions, records in urinary diaries, and scores of three life stress questionnaires (overactive bladdersymptom questionnaire [OAB-q], urogenital distress inventory questionnaire-short form [UDI-6], incontinence impactquestionnaire-short form [IIQ-7]) were performed pre- and post-treatment.Results: Significant reductions (P<0.01) of micturition number and nocturia after magnetic treatment were evidenced.The urodynamic tests recorded a significant increase in cystometric capacity (147±51.3%), in maximumurethral closure pressure (110±34%), in urethral functional length (99.8±51.8%), and in pressure transmissionratio (147±51.3%) values compared with the baseline values.Conclusions: These preliminary findings suggest that FMS with Magneto STYM (twice weekly for 3 weeks) improvesthe UI and may be an effective treatment for this urogenital disease.
Leggi ArticoloCancer is one of the most common causes of death worldwide. Available treatments are associated with numerous side effects and only a low percentage of patients achieve complete remission. Therefore, there is a strong need for new therapeutic strategies. In this regard, pulsed electromagnetic feld (PEMF) therapy presents several potential advantages including non-invasiveness, safety, lack of toxicity for non-cancerous cells, and the possibility of being combined with other available therapies. Indeed, PEMF stimulation has already been used in the context of various cancer types including skin, breast, prostate, hepatocellular, lung, ovarian, pancreatic, bladder, thyroid, and colon cancer in vitro and in vivo. At present, only limited application of PEMF in cancer has been documented in humans. In this article, we review the experimental and clinical evidence of PEMF therapy discussing future perspectives in its use in oncology.
Leggi ArticoloElectromagnetic therapy is a non‑invasive and safe approach for the management of several pathological conditions including neurodegenerative diseases. Parkinson’s disease is a neurodegenerative pathology caused by abnormal degeneration of dopaminergic neurons in the ventral tegmental area and substantia nigra pars compacta in the midbrain resulting in damage to the basal ganglia. Electromagnetic therapy has been extensively used in the clinical setting in the form of transcranial magnetic stimulation, repetitive transcranial magnetic stimulation, high‑frequencytranscranial magnetic stimulation and pulsed electromagnetic feld therapy which can also be used in the domestic setting. In this review, we discuss the mechanisms and therapeutic applications of electromagnetic therapy to alleviate motor and non‑motor defcits that characterize Parkinson’s disease
Leggi Articolo- 1